| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/24/2007 | CN1900061A 5-methoxy-2-perfluoro propyl indole and its preparing method |
| 01/24/2007 | CN1296369C Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate |
| 01/24/2007 | CN1296355C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166720 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 01/23/2007 | US7166638 Statin derivatives |
| 01/23/2007 | US7166637 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them |
| 01/23/2007 | US7166636 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 01/23/2007 | US7166635 3-imino-2-indolones for the treatment of depression and/or anxiety |
| 01/23/2007 | US7166634 Bis-indole pyrroles useful as antimicrobials agents |
| 01/23/2007 | US7166633 Method for synthesising perindopril and the pharmaceutically acceptable salt thereof |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166615 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166607 Substituted indoles |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166400 Organophotoreceptor with a hydrazone polymer charge transport material |
| 01/23/2007 | US7166301 Immediate release medicinal compositions for oral use |
| 01/18/2007 | WO2007008985A2 Kinase inhibitors |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007008664A1 3-spir0cycl0pr0pyl2-0xind0le kinase inhibitors |
| 01/18/2007 | WO2007008564A1 Process for making hydroisoindoline tachykinin receptor antagonists |
| 01/18/2007 | WO2007007885A1 Carbazole derivative, and light emitting element material, light emitting element, and electronic appliance obtained using the same |
| 01/18/2007 | WO2007007646A1 Homogeneous asymmetric hydrogenation catalyst |
| 01/18/2007 | WO2007007054A1 Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
| 01/18/2007 | WO2007006734A1 New benzoheterocyclylethylbenzamide derivatives |
| 01/18/2007 | WO2007006677A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | US20070015923 Process for making hydroisoindoline tachykinin receptor antagonists |
| 01/18/2007 | US20070015922 Process for the preparation of 1,1,3,3-tetraalkylisoindoline starting from n-benzylphthalimide |
| 01/18/2007 | US20070015815 Hydrazide substrate shuts down protein biosynthesis capability in cells that host a metastatic or malignant disease mechanism |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | CA2615007A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 01/18/2007 | CA2612844A1 Process for making hydroisoindoline tachykinin receptor antagonists |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/18/2007 | CA2603115A1 3-spirocyclopropyl2-oxindole kinase inhibitors |
| 01/18/2007 | CA2602453A1 Kinase inhibitors |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |
| 01/17/2007 | EP1742918A1 Lxr receptor modulators |
| 01/17/2007 | EP1742914A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1742912A1 Novel androgens |
| 01/17/2007 | EP1742642A2 Phosphonate analogs of hiv integrase inhibitor compounds |
| 01/17/2007 | EP1603914B1 Compounds having activity at 5ht2c receptor and uses thereof |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/17/2007 | CN1898227A Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/17/2007 | CN1898204A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 01/17/2007 | CN1896075A Processes for producing indole compound |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1896060A Tetrahydro-indolone and tetrahydro-indazolone derivatives and their use |
| 01/17/2007 | CN1896059A Process for separating imide compounds |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295216C Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7164014 Used to produce amino- modified linkers that space an oligonucleotide from a solid support |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/11/2007 | WO2007004165A2 Process for the preparation of perindopril |
| 01/11/2007 | WO2007003947A2 Process for the synthesis of the ace inhibitor trandolapril |
| 01/11/2007 | WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 01/11/2007 | WO2006118955A3 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
| 01/11/2007 | WO2006117669B1 Amide resorcinol compounds |
| 01/11/2007 | WO2006094209A3 N-benzimidazolylalkyl-substituted amide sirtuin modulators |
| 01/11/2007 | WO2006089053A3 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 01/11/2007 | WO2006023720A3 Reactions of enolizable a-amino aldehydes or ketones to form amine |
| 01/11/2007 | US20070010602 Nigrosine dye and process for producing the same |
| 01/11/2007 | US20070010573 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
| 01/11/2007 | US20070010572 Reaction of benzyl (2S)-2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylate with triethylamine and then (2S)-2-[(tert-butoxycarbonyl)amino]propionyl chloride and reaction of product with ethyl 2-oxopentanoate and hydrogenation using platinum on carbon catalyst |
| 01/11/2007 | US20070010571 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
| 01/11/2007 | US20070010568 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection |
| 01/11/2007 | CA2614099A1 Process for the synthesis of the ace inhibitor |
| 01/10/2007 | EP1742052A1 Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 01/10/2007 | EP1741700A1 Process for the preparation of carvedilol |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
| 01/10/2007 | EP1740573A1 Amides as bace inhibitors |
| 01/10/2007 | EP1740539A2 Preparation of tegaserod and tegaserod maleate |
| 01/10/2007 | EP1740538A2 Bicyclic heterocycles useful as serine protease inhibitors |
| 01/10/2007 | EP1740173A1 Azabicyclo-octane inhibitors of iap |
| 01/10/2007 | EP1740171A1 Indol-1-yl-acetic acid derivatives |
| 01/10/2007 | EP1560806B1 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives |
| 01/10/2007 | EP1355632B1 Amlodipine free base |
| 01/10/2007 | CN1894249A Spiropiperidine derivatives for controlling pests |
| 01/10/2007 | CN1894238A Diamine derivatives |
| 01/10/2007 | CN1894235A N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 01/10/2007 | CN1894213A Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 01/10/2007 | CN1894212A Near-infrared fluorescent contrast medium |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/10/2007 | CN1893936A ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis |
| 01/10/2007 | CN1294180C Preparation method of poly (diimide ether) |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/09/2007 | US7161035 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |